Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM90A20 (family with sequence similarity 90 member A20) appears to be either a pseudogene or a putative/uncharacterized protein in the human genome. Scientific literature and protein databases do not ascribe any confirmed biological function, molecular activity, or disease association to FAM90A20. It is *not* part of the Fam20 secretory pathway kinase family (which includes FAM20A, FAM20B, and FAM20C—genes involved in extracellular protein phosphorylation, biomineralization, and rare genetic diseases)[1][2][3]. No evidence supports FAM90A20 as a therapeutic target, and it is not associated with known drugs, mechanisms of action, or biomarker use. The abundance of alternate names reflects its listing as a putative gene/protein in genomic references, rather than as a characterized target. **Note:** FAM90A20 is often confused with FAM20A, a genuine pseudokinase involved in critical secretory phosphorylation processes; these are distinct. If you are seeking information about FAM20A or other thoroughly studied Fam20 proteins, refer specifically to those gene names[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A20 (FAM90A20).